Chest pain screening for hidden cardiac amyloidosis
Official title: CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Run by Copenhagen University Hospital, Rigshospitalet · NCT07435168 · Data updated 2026-11-12
We will test whether men over 65 who have chest pain but no coronary artery disease might have hidden cardiac amyloidosis using blood and urine tests, ECG and echocardiography, bone scintigraphy, and sometimes a heart biopsy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | Men only |
| Enrollment | 300 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT07435168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Men over 65 with chest pain who have had a CT coronary angiogram or Rb-PET showing no coronary artery disease and who do not have a prior history of amyloidosis.
✕Probably not a fit
Patients who are female, younger than 65, have confirmed coronary artery disease on imaging, or already have a diagnosis of amyloidosis are unlikely to benefit from this screening-focused study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational study enrolling men older than 65 who present with chest pain but have no evidence of coronary artery disease on CT coronary angiography or Rb-PET. Participants will undergo blood and urine sampling, ECG, transthoracic echocardiography, and bone scintigraphy to look for signs of cardiac amyloid, with endomyocardial biopsy reserved for inconclusive cases. The primary aim is to determine the prevalence of cardiac amyloidosis in this defined chest-pain population. Data collected at Rigshospitalet will inform whether routine screening in similar patients is warranted.
Why it matters
Potential benefit: If successful, the study could identify men with previously unrecognized cardiac amyloidosis earlier, enabling earlier management and appropriate follow-up.
How similar studies have gone: Noninvasive bone scintigraphy for transthyretin cardiac amyloidosis has been validated and prevalence studies in older adults with heart failure or aortic stenosis have shown notable rates, but applying this approach specifically to chest-pain patients without CAD is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: No signs of CAD through Rb-PET and/or CT coronary arteriogram Exclusion Criteria: Previous history of amyloidosis
Where it's running
-
Rigshospitalet
Copenhagen, Denmark Recruiting
Study contacts
- Study coordinator: Navid Noory, MD
- Email: navid.noory@regionh.dk
- Phone: 4535453108
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartwatch 9-lead ECG vs 12-lead ECG to detect STEMI in chest pain patients
We are testing whether a smartwatch ECG can help diagnose STEMI in people with chest pain.
-
Liver and Coagulation Markers in ATTR Cardiac Amyloidosis
This study tests liver function and blood-clotting markers in people with ATTR-CA to see if they reflect disease severity and progression.
-
Cardiac Amyloidosis: See if Intracardiac Thrombi are Common on CT
This study tests whether a contrast-enhanced cardiac CT can reliably detect intracardiac thrombi in adults with cardiac amyloidosis.
-
ML-based diagnosis of blocked arteries in patients with a left bundle branch block
Doctors are testing a machine learning tool that uses digital ECGs to see if a blocked coronary artery is present in patients with a left bundle branch block.
-
Higher pacemaker rate for people with cardiac amyloidosis
This study will see if temporarily increasing the pacemaker rate improves heart-failure symptoms and exercise tolerance in adults with cardiac amyloidosis who already have pacemakers.
-
Hormones, Pain, and Exercise: Sports Bras for Full-Busted Women
This study tests whether specially designed sports bras can reduce neck, shoulder, arm, and back pain in full-busted women, and whether hormones, inflammation, or brain changes affect pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.